REVMATIZM VA HOMILADORLIK: XAVF OMILLARI VA MONITORING
Ключевые слова:
Keywords: rheumatism, pregnancy, autoimmune diseases, risk factors, monitoring, multidisciplinary approach, systemic lupus erythematosus, rheumatoid arthritis.Аннотация
Abstract. Rheumatic diseases, including systemic lupus erythematosus (SLE), rheumatoid arthritis (RA), antiphospholipid syndrome (APS), and scleroderma, can significantly impact maternal and fetal health during pregnancy. Hormonal and immunological changes during pregnancy may alter the clinical course of these autoimmune conditions, leading to disease flares, preeclampsia, miscarriage, preterm birth, and intrauterine growth restriction. This article comprehensively covers the risk factors of pregnancy in the context of rheumatic diseases, management strategies, and monitoring methods. Pre-pregnancy disease remission, the use of safe medications, and a multidisciplinary approach with regular medical follow-up are of critical importance. Based on modern clinical research and statistical data, the article provides recommendations for the successful management of pregnancy in women with rheumatic diseases.
Библиографические ссылки
1. Abduazizova, N. X., Abdullaeva, N. X., & Samaraxonova, Sh. J. (2022). Homiladorlik davrida tizimli qizil yuguruk kasalligining kechishi va davolash tamoyillari. Toshkent Medical Academy Repository.
2. Andreoli, L., Bertsias, G. K., Agmon-Levin, N., Brown, S., Cervera, R., Costedoat-Chalumeau, N., … Tincani, A. (2017). EULAR recommendations for women's health and the management of family planning, assisted reproduction, pregnancy and menopause in patients with systemic lupus erythematosus and/or antiphospholipid syndrome. Annals of the Rheumatic Diseases, 76(3), 476–485. https://doi.org/10.1136/annrheumdis-2016-209770
3. Buyon, J. P., Kim, M. Y., Guerra, M. M., Laskin, C. A., Petri, M., Lockshin, M. D., & Branch, D. W. (2015). Predictors of pregnancy outcomes in patients with lupus: A prospective study. Annals of Internal Medicine, 163(3), 153–163. https://doi.org/10.7326/M14-2235
4. Clowse, M. E. B. (2007). Lupus activity in pregnancy. Rheumatic Disease Clinics of North America, 33(2), 237–252. https://doi.org/10.1016/j.rdc.2007.03.003
5. Clowse, M. E. B., Jamison, M., Myers, E., & James, A. H. (2008). A national study of the complications of lupus in pregnancy. American Journal of Obstetrics and Gynecology, 199(2), 127.e1–127.e6. https://doi.org/10.1016/j.ajog.2008.03.012
6. de Jesus, G. R., Mendoza-Pinto, C., de Jesus, N. R., Dos Santos, F. C., Klumb, E. M., & Levy, R. A. (2014). Understanding and managing pregnancy in patients with lupus. Autoimmune Diseases, 2014, Article 943490. https://doi.org/10.1155/2014/943490
7. Giles, I., Yee, C. S., & Gordon, C. (2019). Managing pregnancy in systemic lupus erythematosus. BMJ, 367, l5877. https://doi.org/10.1136/bmj.l5877
8. To‘lqinov, I. M., & Yulchiyev, A. B. (2023). Revmatizm kasalligini davolashda ishlatiladigan antibiotiklarning kimyoviy tarkibi va S vitaminining ahamiyati. Innovative Development in Educational Activities, 2(7), 247–253. openidea.uz
